[B031] Medical News

get
https://connect.patsnap.com/synapse/news
Try in Sandbox

Obtain news about title, content, publish date etc.

Request Parameters

List of parameters supported by this API endpoint

NameTypeExampleDescription
news_id
Required
stringf57e970e-8f97-39b7-a6be-51846e92bee1
News ID, obtain this through the [B045] medical news search interface

Response Schema

Structure of the API response data

Field NameTypeExampleDescription
data
object-
response data
drug
array[ { "drug_id": "e82b83b42eba4e5ea3f26f8e06081a5a", "display_name": [ { "lang": "EN", "name": "Ranibizumab (Genentech)" }, { "lang": "CN", "name": "雷珠单抗" } ] } ]
Drug, Referencing "CommonDrug"
drug_id
stringe82b83b42eba4e5ea3f26f8e06081a5a
Drug ID
display_name
array[ { "lang": "EN", "name": "Ranibizumab (Genentech)" }, { "lang": "CN", "name": "雷珠单抗" } ]
Drug Name, Referencing "CommonName"
lang
stringEN
Language
name
stringRanibizumab (Genentech)
Drug,Target,Organization,Disease,Country/Location,DICT,Mechanism Action Name
tags
array[ "Careers", "Resume", "BioSpace", "advice" ]
News Tags
title
stringRoche to reintroduce Susvimo in the US for people with neovascular age-related macular degeneration (nAMD)
News title
author
array[ "Thomas Fink" ]
Author
target
array[ { "target_id": "1c2067e5ab054a8995f73efcfcf56207", "short_name": [ { "lang": "EN", "name": "VEGF" } ], "display_name": [ { "lang": "EN", "name": "Vascular endothelial growth factor" }, { "lang": "CN", "name": "血管内皮生长因子" } ] } ]
Target, Referencing "CommonTarget"
target_id
string1c2067e5ab054a8995f73efcfcf56207
Target ID
short_name
array[ { "lang": "EN", "name": "VEGF" } ]
Target Short Name, Referencing "CommonName"
display_name
array[ { "lang": "EN", "name": "Vascular endothelial growth factor" }, { "lang": "CN", "name": "血管内皮生长因子" } ]
Target Full Name, Referencing "CommonName"
channel
array[ "company information" ]
News Channel
content
stringThe FDA has approved updates to Susvimo, which will be available to US retina specialists and patients with nAMD in the coming weeks\nSusvimo offers the first alternative to regular eye injections that are standard of care for nAMD, which impacts 20 million people worldwide and can cause blindness if left untreated
News content
disease
array[ { "disease_id": "06a9082fe1ec4c97bea31d888b9cfdce", "display_name": [ { "lang": "EN", "name": "Uveitic Macular Edema" }, { "lang": "CN", "name": "葡萄膜炎黄斑水肿" } ] } ]
Disease, Referencing "CommonDisease"
disease_id
string06a9082fe1ec4c97bea31d888b9cfdce
Disease ID
display_name
array[ { "lang": "EN", "name": "Uveitic Macular Edema" }, { "lang": "CN", "name": "葡萄膜炎黄斑水肿" } ]
Disease Name, Referencing "CommonName"
news_id
stringf57e970e-8f97-39b7-a6be-51846e92bee1
News ID
post_time
integer<int64>1720600697798
Post Time
source_url
stringhttps://www.biospace.com/article/releases/cerevel-therapeutics-announces-publication-in-the-lancet-of-emraclidine-data-from-phase-1b-clinical-trial-in-people-living-with-schizophrenia/
News Link
organization
array[ { "display_name": [ { "lang": "EN", "name": "Roche Holding AG" }, { "lang": "CN", "name": "罗氏" } ], "organization_id": "87bfaf037f8e60c9e25595cd98bb27e4" } ]
Organization, Referencing "CommonOrganization"
display_name
array[ { "lang": "EN", "name": "Roche Holding AG" }, { "lang": "CN", "name": "罗氏" } ]
Organization Name, Referencing "CommonName"
organization_id
string87bfaf037f8e60c9e25595cd98bb27e4
Organization ID
status
Required
booleanfalse
Status
error_msg
stringThe request parameter format is incorrect!
Error Message
error_code
Required
integer0
Error Code

Success Response Example

Example of a successful API response

JSON
{
  "data": {
    "drug": [
      {
        "drug_id": "e82b83b42eba4e5ea3f26f8e06081a5a",
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ]
      }
    ],
    "tags": [
      "Careers",
      "Resume",
      "BioSpace",
      "advice"
    ],
    "title": "Roche to reintroduce Susvimo in the US for people with neovascular age-related macular degeneration (nAMD)",
    "author": [
      "Thomas  Fink"
    ],
    "target": [
      {
        "target_id": "1c2067e5ab054a8995f73efcfcf56207",
        "short_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ],
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ]
      }
    ],
    "channel": [
      "company information"
    ],
    "content": "The FDA has approved updates to Susvimo, which will be available to US retina specialists and patients with nAMD in the coming weeks\\nSusvimo offers the first alternative to regular eye injections that are standard of care for nAMD, which impacts 20 million people worldwide and can cause blindness if left untreated",
    "disease": [
      {
        "disease_id": "06a9082fe1ec4c97bea31d888b9cfdce",
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ]
      }
    ],
    "news_id": "f57e970e-8f97-39b7-a6be-51846e92bee1",
    "post_time": 1720600697798,
    "source_url": "https://www.biospace.com/article/releases/cerevel-therapeutics-announces-publication-in-the-lancet-of-emraclidine-data-from-phase-1b-clinical-trial-in-people-living-with-schizophrenia/",
    "organization": [
      {
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ],
        "organization_id": "87bfaf037f8e60c9e25595cd98bb27e4"
      }
    ]
  },
  "status": true,
  "error_code": 0
}

Error Codes

List of possible error codes returned by this endpoint

Business Errors

Error CodeDescription
68300004Invalid parameter!
68300005Search api failure!
68300006Analytic basic access error!
68300007Bad request!
68300008Service error, please try again later!
68300010The file does not comply with upload specifications!

Platform Errors

Error CodeDescription
67200001API call exceeds the total limit set by the platform!
67200002Quota exceeds the limit!
67200003Access token expired or authentication error!
67200004No permission or API package quota has exceeded the limit!
67200005Insufficient balance, call failed!
67200006This client has expired and call failed!
67200007Exceeded the call limit, call failed!

HTTP Status Codes

Status CodeDescription
0Success
401Unauthorized
403Forbidden
404Not Found